The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no ...

Gradient Denervation Technologies announced today that it received FDA breakthrough device designation for its denervation ...

The following is a summary of "Prognostic value of non-invasive right ventricle-pulmonary artery coupling in patients with ...

Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but ...

Cardiac output and stroke volume as measured by impedance cardiography may hold potential to predict clinical deterioration ...

Foresee Pharma begins patient dosing in phase 2 WINDWARD study of mirivadelgat to treat pulmonary hypertension-associated interstitial lung disease: Taipei, Taiwan Friday, May 16, ...

Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device ...

Gradient Denervation Technologies, which is based in Paris, France, announced that the company’s pulmonary artery denervation ...

Data demonstrates CorVista’s proprietary machine-learned algorithm detects elevated mean pulmonary artery pressure (mPAP) ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Research has found that drinking beetroot (beet) juice daily can help lower blood pressure. Here’s why and how you can drink ...